403 related articles for article (PubMed ID: 32414858)
41. Multiplex Immunohistochemistry Staining for Paraffin-embedded Lung Cancer Tissue.
Yang Y; Huang H; Li L; Yang Y
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38078595
[TBL] [Abstract][Full Text] [Related]
42. PD-L1 Multiplex and Quantitative Image Analysis for Molecular Diagnostics.
Abdullahi Sidi F; Bingham V; Craig SG; McQuaid S; James J; Humphries MP; Salto-Tellez M
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374775
[TBL] [Abstract][Full Text] [Related]
43. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
[TBL] [Abstract][Full Text] [Related]
44. Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.
Brunner A; Willenbacher E; Willenbacher W; Zelger B; Zelger P; Huck CW; Pallua JD
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121940. PubMed ID: 36208576
[TBL] [Abstract][Full Text] [Related]
45. Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues.
Sun B; Laberiano-Fernández C; Salazar-Alejo R; Zhang J; Solorzano Rendon JL; Lee J; Solis Soto LM; Wistuba II; Parra ER
Pathobiology; 2023; 90(1):1-12. PubMed ID: 35609532
[TBL] [Abstract][Full Text] [Related]
46. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2.
Lopes N; Bergsland CH; Bjørnslett M; Pellinen T; Svindland A; Nesbakken A; Almeida R; Lothe RA; David L; Bruun J
Lab Invest; 2020 Jan; 100(1):120-134. PubMed ID: 31641225
[TBL] [Abstract][Full Text] [Related]
47. Comparison of Multiplexed Immunofluorescence Imaging to Chromogenic Immunohistochemistry of Skin Biomarkers in Response to Monkeypox Virus Infection.
Sood A; Sui Y; McDonough E; Santamaría-Pang A; Al-Kofahi Y; Pang Z; Jahrling PB; Kuhn JH; Ginty F
Viruses; 2020 Jul; 12(8):. PubMed ID: 32717786
[TBL] [Abstract][Full Text] [Related]
48. Overview of Tissue Imaging Methods.
Patel SS; Rodig SJ
Methods Mol Biol; 2020; 2055():455-465. PubMed ID: 31502165
[TBL] [Abstract][Full Text] [Related]
49. Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications.
Kumar G; Pandurengan RK; Parra ER; Kannan K; Haymaker C
Front Immunol; 2023; 14():1288802. PubMed ID: 38179056
[TBL] [Abstract][Full Text] [Related]
50. Comparison of different predictive biomarker testing assays for PD-1/PD-L1 checkpoint inhibitors response: a systematic review and network meta-analysis.
Shi H; Zhang W; Zhang L; Zheng Y; Dong T
Front Immunol; 2023; 14():1265202. PubMed ID: 37822932
[TBL] [Abstract][Full Text] [Related]
51. Utilisation of cytological samples for multiplex immunofluorescence assay.
Tobar LG; Villalba-Esparza M; Abengozar-Muela M; Alvarez Gigli L; Echeveste JI; de Andrea CE; Lozano MD
Cytopathology; 2021 Sep; 32(5):611-616. PubMed ID: 33870575
[TBL] [Abstract][Full Text] [Related]
52. Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment.
Widodo SS; Hutchinson RA; Fang Y; Mangiola S; Neeson PJ; Darcy PK; Barrow AD; Hovens CM; Dinevska M; Stylli SS; Mantamadiotis T
Cancer Immunol Immunother; 2021 Jul; 70(7):1811-1820. PubMed ID: 33389014
[TBL] [Abstract][Full Text] [Related]
53. Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence.
Tien TZ; Lee JNLW; Lim JCT; Chen XY; Thike AA; Tan PH; Yeong JPS
Histopathology; 2021 Aug; 79(2):139-159. PubMed ID: 33400265
[TBL] [Abstract][Full Text] [Related]
54. High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers.
Banik G; Betts CB; Liudahl SM; Sivagnanam S; Kawashima R; Cotechini T; Larson W; Goecks J; Pai SI; Clayburgh DR; Tsujikawa T; Coussens LM
Methods Enzymol; 2020; 635():1-20. PubMed ID: 32122539
[TBL] [Abstract][Full Text] [Related]
55. Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy.
Hu W
Thorac Cancer; 2020 Jan; 11(1):3-5. PubMed ID: 31722117
[No Abstract] [Full Text] [Related]
56. Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging.
Locke D; Hoyt CC
Front Mol Biosci; 2023; 10():1051491. PubMed ID: 36845550
[TBL] [Abstract][Full Text] [Related]
57. Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system.
Anyaegbu CC; Lee-Pullen TF; Miller TJ; Abel TN; Platell CF; McCoy MJ
J Immunol Methods; 2019 Sep; 472():25-34. PubMed ID: 31181211
[TBL] [Abstract][Full Text] [Related]
58. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.
Parra ER; Uraoka N; Jiang M; Cook P; Gibbons D; Forget MA; Bernatchez C; Haymaker C; Wistuba II; Rodriguez-Canales J
Sci Rep; 2017 Oct; 7(1):13380. PubMed ID: 29042640
[TBL] [Abstract][Full Text] [Related]
59. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG
J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863
[TBL] [Abstract][Full Text] [Related]
60. Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology.
Hoyt CC
Front Mol Biosci; 2021; 8():674747. PubMed ID: 34150850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
